Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Preferred Shares (2020 - 2023)

Ovid Therapeutics (OVID) has disclosed Preferred Shares for 4 consecutive years, with $1.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Preferred Shares changed 0.0% year-over-year to $1.0, compared with a TTM value of $1.0 through Sep 2023, changed 0.0%, and an annual FY2022 reading of $1.0, changed 0.0% over the prior year.
  • Preferred Shares was $1.0 for Q3 2023 at Ovid Therapeutics, roughly flat from $1.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $8.0 in Q1 2020 and bottomed at $1.0 in Q1 2021.
  • Average Preferred Shares over 4 years is $2.27, with a median of $1.0 recorded in 2021.
  • The sharpest move saw Preferred Shares plummeted 87.5% in 2021, then changed 0.0% in 2022.
  • Year by year, Preferred Shares stood at $3.0 in 2020, then crashed by 66.67% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
  • Business Quant data shows Preferred Shares for OVID at $1.0 in Q3 2023, $1.0 in Q2 2023, and $1.0 in Q1 2023.